Delivery Order SPE2DB22D1017-SPE2DB24FF7XJ

Award Date 5/17/24
Potential Completion Date 5/20/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 mL pen. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $1,415.44 and a completion date of July 29, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025....
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,939.84 and a completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $1,506.00 delivery order contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical drug Mounjaro (5 mg/0.5 ml pen) to the Medical Supply Chain, a defense agency under the Department of Defense. The contract has a ceiling value of $1,054.32 and a completion date of May 6, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen with a ceiling value of $2,630.00. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Mounjaro 7.5 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $1,632.54 and has an ultimate completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the procurement of pharmaceutical products, specifically the drug Mounjaro 10 mg/0.5 mL pen, for a ceiling value of $2,448.84. The contract is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,841. The contract is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The $5,291.68 firm fixed price contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA), with a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen with a ceiling value of $1,578.00. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract has a period of performance through June 5, 2024 and was awarded on June 4, 2024 with no set-aside designation....
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF7XJ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen 0.5 ml. The award, valued at $4,044.85, was made by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 20, 2024.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract award does not have a set-aside designation.

Generated 8/16/24, 10:15 AM